Skip to main content

Advertisement

Table 1 Hypothetical case study of the estimated financial costs of using different treatment strategies within the Kenyan national STH control programme

From: Programmatic implications of the TUMIKIA trial on community-wide treatment for soil-transmitted helminths: further health economic analyses needed before a change in policy

StrategyNumber treatedAssumed cost per treatment (US$)Estimated total financial cost per year (US$)
School-based treatment6 million children [23]0.30b–0.56c1.8–3.4 million
Community-wide treatment14 million individualsa0.32d–0.46e4.4–6.4 million
  1. aApproximated based on demographic data from the World Bank [24]
  2. bBased on the WHO MDA cost benchmark model [25]
  3. cEstimate from Evidence Action (a programmatic estimate for 2015) [23]
  4. dBased on the estimate from the TUMIKIA trial [4]: routine scenario (excluding the research costs) relating to whole county (i.e. estimate at scale). US$0.025 per treatment was added for the cost of albendazole [4]
  5. eBased on the estimate from the TUMIKIA trial [4]—routine scenario (excluding the research costs) relating to trial areas only. US$0.025 per treatment was added for the cost of albendazole [4]